Imaging [18F]AV-1451 and [18F]AV-45 in Acute and Chronic Traumatic Brain Injury
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Jan 2018
At a glance
- Drugs Florbetapir F 18 (Primary) ; Flortaucipir-F-18 (Primary)
- Indications Brain injuries; Mild cognitive impairment
- Focus Diagnostic use
- 02 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
- 02 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Feb 2018.
- 02 Jan 2018 Status changed from recruiting to active, no longer recruiting.